stockrowCronos Group Inc. (CRON) vs Pacira BioSciences, Inc. (PCRX)
- Cronos Group Inc. CRON 3.60 −3.23%
- Pacira BioSciences, Inc. PCRX 36.44 +0.05%
Cronos Group Inc. and Pacira BioSciences, Inc. are both Drug Manufacturers Specialty & Generic companies. Cronos Group Inc. and Pacira BioSciences, Inc. are of similar size ($1.5B and $1.4B). Cronos Group Inc. trades at the lower P/E: 21.9× against 38.4×. Cronos Group Inc. grew revenue faster over the last twelve months: 55.8% against 3.70%. Cronos Group Inc. has the higher net margin (28.0% vs 5.08%) and the lower return on invested capital (1.28% vs 5.37%). Across the 22 metrics below, Cronos Group Inc. leads on 11 and Pacira BioSciences, Inc. on 11.
Valuation
Profitability
| Metric | CRON | PCRX | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 46.59% | 0.00% | 53.51% |
| Operating margin | 3.78% | 4.81% | 0.00% |
| Net margin | 28.04% | 5.08% | (2.45%) |
| Free cash flow margin | 31.71% | 22.74% | 0.00% |
| Return on equity | 5.12% | 5.24% | (0.80%) |
| Return on assets | 4.87% | 3.02% | (1.67%) |
| Return on invested capital | 1.28% | 5.37% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack